COCM
ABBV icon

Charter Oak Capital Management’s AbbVie ABBV Stock Holding History

Charter Oak Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
8,374
-23
-0.3% -$5.1K 0.14% 51
2025
Q4 		$1.92M Sell
8,397
-44
-0.5% -$10K 0.15% 49
2025
Q3 		$1.95M Sell
8,441
-230
-3% -$46.8K 0.15% 47
2025
Q2 		$1.61M Buy
8,671
+134
+2% +$24.9K 0.14% 52
2025
Q1 		$1.79M Buy
8,537
+78
+0.9% +$15.2K 0.16% 45
2024
Q4 		$1.5M Sell
8,459
-333
-4% -$61.2K 0.14% 54
2024
Q3 		$1.74M Buy
8,792
+712
+9% +$133K 0.16% 48
2024
Q2 		$1.39M Sell
8,080
-148
-2% -$24.5K 0.14% 57
2024
Q1 		$1.5M Buy
8,228
+357
+5% +$61.5K 0.16% 53
2023
Q4 		$1.22M Buy
7,871
+356
+5% +$51.9K 0.14% 57
2023
Q3 		$1.12M Sell
7,515
-9
-0.1% -$1.32K 0.15% 58
2023
Q2 		$1.01M Buy
7,524
+12
+0.2% +$1.76K 0.13% 67
2023
Q1 		$1.2M Buy
7,512
+8
+0.1% +$1.22K 0.17% 58
2022
Q4 		$1.21M Buy
7,504
+11
+0.1% +$1.69K 0.18% 59
2022
Q3 		$1.01M Buy
7,493
+163
+2% +$23.4K 0.16% 60
2022
Q2 		$1.12M Sell
7,330
-38
-0.5% -$5.81K 0.15% 62
2022
Q1 		$1.19M Buy
7,368
+841
+13% +$122K 0.15% 63
2021
Q4 		$884K Buy
6,527
+73
+1% +$8.62K 0.1% 83
2021
Q3 		$696K Buy
6,454
+32
+0.5% +$3.66K 0.09% 92
2021
Q2 		$723K Buy
6,422
+198
+3% +$22.3K 0.09% 91
2021
Q1 		$674K Buy
6,224
+97
+2% +$10.4K 0.09% 94
2020
Q4 		$657K Buy
+6,127
New +$589K 0.1% 92

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charter Oak Capital Management's ABBV Position: Q1 2026 in Review

Charter Oak Capital Management reduced its AbbVie (ABBV) stake by 0.27% in Q1 2026, selling an estimated $5.1K and leaving 8,374 shares worth $1.82M. The position accounts for 0.14% of the portfolio, ranked #51.

Charter Oak Capital Management first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.95M in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Charter Oak Capital Management held 8,374 shares of AbbVie worth $1.82M as of Q1 2026.
  • Charter Oak Capital Management sold 23 AbbVie shares in Q1 2026, an estimated $5.1K.
  • AbbVie made up 0.14% of Charter Oak Capital Management's portfolio in Q1 2026, its #51 holding.
  • Charter Oak Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Charter Oak Capital Management's AbbVie position peaked at $1.95M in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.